Intellectual property rights/inventor/patent holder; (SAB) Scientific advisory board Introduction. Radiation-induced sarcoma (RIS) is a rare, aggressive malignancy. Breast cancer survivors treated with radiotherapy constitute a large fraction of RIS pa-tients. To evaluate evidenced-based practices for RIS treat-ment, we performed a systematic review of the publishe
Abstract: Breast cancer is the most common cancer in women worldwide and encompasses a broad spectru...
Abstract BACKGROUND: Angiosarcoma (AS) accounts for 1 to 2% of all soft tissue sarcoma. Both primary...
Purpose: Postradiation sarcoma, a sarcoma developing in a previously irradiated field, is a rare tum...
Radiation induced sarcomas (RIS) are rare complications of radiotherapy that occur from a previously...
Radiation-induced breast sarcomas (RIBS) are rare entities representing <1% of all primary breast...
A retrospective analysis was performed of 46 cases of sarcoma treated in our institution between 198...
Intellectual property rights/inventor/patent holder; (SAB) Scientific advisory board Introduction. M...
Background: Treatment of radiation-induced sarcoma (RIS) remains an unsolved problem. To provide mor...
Background: Treatment of a radiation-induced sarcoma (RIS) remains an unsolved problem. To provide m...
Background: Treatment of radiation-induced sarcoma (RIS) remains an unsolved problem. To provide mor...
BACKGROUND: Angiosarcoma may rarely complicate radiotherapy of breast cancer. This so-called radiati...
Radiation-associated sarcoma (RAS) is a rare complication of radiation therapy (RT) to breast cancer...
doi: 10.3389/fonc.2013.00073 Radiotherapy-induced malignancies: review of clinical features, pathobi...
Sarcoma of the breast is usually seen following radiation therapy. Radiation-induced sarcoma treatme...
Purpose: Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discus...
Abstract: Breast cancer is the most common cancer in women worldwide and encompasses a broad spectru...
Abstract BACKGROUND: Angiosarcoma (AS) accounts for 1 to 2% of all soft tissue sarcoma. Both primary...
Purpose: Postradiation sarcoma, a sarcoma developing in a previously irradiated field, is a rare tum...
Radiation induced sarcomas (RIS) are rare complications of radiotherapy that occur from a previously...
Radiation-induced breast sarcomas (RIBS) are rare entities representing <1% of all primary breast...
A retrospective analysis was performed of 46 cases of sarcoma treated in our institution between 198...
Intellectual property rights/inventor/patent holder; (SAB) Scientific advisory board Introduction. M...
Background: Treatment of radiation-induced sarcoma (RIS) remains an unsolved problem. To provide mor...
Background: Treatment of a radiation-induced sarcoma (RIS) remains an unsolved problem. To provide m...
Background: Treatment of radiation-induced sarcoma (RIS) remains an unsolved problem. To provide mor...
BACKGROUND: Angiosarcoma may rarely complicate radiotherapy of breast cancer. This so-called radiati...
Radiation-associated sarcoma (RAS) is a rare complication of radiation therapy (RT) to breast cancer...
doi: 10.3389/fonc.2013.00073 Radiotherapy-induced malignancies: review of clinical features, pathobi...
Sarcoma of the breast is usually seen following radiation therapy. Radiation-induced sarcoma treatme...
Purpose: Radiation-induced sarcoma (RIS) is a rare but serious event. Its occurrence has been discus...
Abstract: Breast cancer is the most common cancer in women worldwide and encompasses a broad spectru...
Abstract BACKGROUND: Angiosarcoma (AS) accounts for 1 to 2% of all soft tissue sarcoma. Both primary...
Purpose: Postradiation sarcoma, a sarcoma developing in a previously irradiated field, is a rare tum...